Jacob S Warner-Palacio

Dr. Jacob S Warner-Palacio

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 December 2023 in Urology
Verified
Journal Article
Closed access
HLHenry Larson
Henry Larson
JWJacob S Warner-Palacio
Jacob S Warner-Palacio
JSJoshua Savage
Joshua Savage
TKTobias Kohler
Tobias Kohler
MZMatthew Ziegelmann
Matthew Ziegelmann
LTLandon Trost
Landon Trost

Verified
Journal Article
Open access
PDF file
JWJacob S Warner-Palacio
Jacob S Warner-Palacio
ZPZackery Paxton
Zackery Paxton
AHAlexis Hassiak
Alexis Hassiak
SWSpencer Willardson
Spencer Willardson
DEDustin Edmonds
Dustin Edmonds
DSDavid Sant
David Sant
Ultrasound therapy has emerged as a promising non-invasive approach for fat reduction with the potential to improve metabolic health with both high-frequency (1–3 MHz) and low-frequency (35–300 kHz) ultrasound receiving FDA approval for waist circumference reduction between 2010 and 2014. This literature review aims to investigate the current state of research regarding the physiological mechanisms underlying ultrasound-induced lipolysis and lipid mobilization. While many studies focus on the esthetic benefits of lipolytic ultrasound, less attention has been given to the metabolic fate of liberated lipids and whether therapeutic ultrasound can influence systemic health. A literature search was conducted using PubMed to identify clinical trials and mechanistic studies on ultrasound-based fat reduction, with emphasis on peer-reviewed articles published within the past five years. Reported results show average waist circumference reductions of 0.5–3.12 inches and modest weight loss of 0.47–2.5 pounds following three treatment sessions. Existing literature suggests that lipid byproducts may enter systemic circulation, and adjunctive therapies such as lymphatic drainage and aerobic exercise may support their clearance or oxidation. However, studies directly investigating post-lipolytic metabolism are limited. This review synthesizes current findings and proposed mechanisms; and highlights the need for further investigation into the metabolic consequences of ultrasound-induced lipolysis.

7 July 2026 in Biology
Verified
Journal Article
Open access
PDF file
JWJacob S Warner-Palacio
Jacob S Warner-Palacio
HHHannah Hunsaker
Hannah Hunsaker
AMAmanda McKenna
Amanda McKenna
BBBrigita Budginas
Brigita Budginas
LFLevi Fridriksson
Levi Fridriksson
KBKyle B. Bills
Kyle B. Bills
Background: Glycemic control influences a wide range of psychiatric and physiological symptoms. Many psychiatric conditions are linked to poor glucose regulation. Anti-nuclear antibodies (ANAs), widely used to screen for autoimmune disease, may sometimes reflect transient metabolic immune activation rather than chronic pathology. Evidence suggests that glucose dysregulation, including glycemic variability, reactive hypoglycemia, and postprandial spikes, can trigger systemic inflammation, neuropsychiatric symptoms, and temporary autoantibody production. This review explores how these metabolic phenomena complicate diagnosis and may contribute to misclassification or overtreatment. Methods: We conducted a narrative literature review prioritizing studies on immune activation, psychiatric outcomes, metabolic measures (including continuous glucose monitoring), and therapeutic interventions. Articles from the last ten years were emphasized, with older foundational studies included when relevant. Results: Metabolic instability drives immune dysregulation through macrophage polarization, mitochondrial dysfunction, oxidative stress, and impaired clearance of apoptotic debris. Glycemic variability correlates with increased inflammatory cytokines, autonomic dysfunction, and psychiatric symptoms such as anxiety, depression, and cognitive impairment. Emerging evidence from small studies suggests that correcting glucose abnormalities may reduce metabolic dysfunction and improve neuropsychiatric symptoms. Conclusions: Recognizing glucose dysregulation as a contributor to autoimmune-like and psychiatric symptoms may refine diagnostic and therapeutic approaches. Incorporating a dynamic holistic approach, which in practice includes metabolic assessments, dietary interventions, use of continuous glucose monitoring, and history of blood sugar instability, into rheumatologic and psychiatric evaluations could improve diagnostic precision, reduce unnecessary immunosuppression, and enhance patient outcomes.

21 September 2026 in Psychiatry Research Case Reports
Verified
Journal Article
Open access
JWJacob S Warner-Palacio
Jacob S Warner-Palacio
HHHannah Hunsaker
Hannah Hunsaker
CNChristina Nelson
Christina Nelson
JWJulian Warner-Palacio
Julian Warner-Palacio
DSDavid Sant
David Sant
KBKyle B Bills
Kyle B Bills